Unigene Laboratories Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2008
2009
2010
2011
2012
Sales/Revenue
19,229.40
12,791.80
11,340.20
20,508.30
9,438.20
Cost of Goods Sold (COGS) incl. D&A
5,621.70
2,171.20
2,608.10
1,551.60
1,639.00
Gross Income
13,607.70
10,620.60
8,732.10
18,956.70
7,799.20
SG&A Expense
18,334.30
22,647.10
16,994.10
21,248.70
13,555.10
EBIT
4,950.00
12,026.50
8,978.90
2,292.00
8,985.10
Unusual Expense
66.20
5,597.20
8,492.10
350.00
11,413.00
Non Operating Income/Expense
-
-
-
824.20
82.80
Interest Expense
2,102.40
4,862.30
11,299.30
10,924.00
13,858.20
Pretax Income
7,004.00
13,446.80
28,569.00
18,526.70
35,547.20
Income Tax
925.60
67.10
700.50
601.10
1,261.00
Consolidated Net Income
6,078.40
13,379.70
27,868.50
17,925.70
34,286.20
Net Income
6,078.40
13,379.70
27,868.50
17,925.70
34,286.20
Net Income After Extraordinaries
6,078.40
13,379.70
27,868.50
17,925.70
34,286.20
Net Income Available to Common
6,078.40
13,379.70
27,868.50
17,925.70
34,286.20
EPS (Basic)
0.07
0.15
0.30
0.19
0.36
Basic Shares Outstanding
88,751.30
90,662.10
91,961.70
93,181.40
95,451.70
EPS (Diluted)
0.07
0.15
0.30
0.19
0.36
Diluted Shares Outstanding
88,751.30
90,662.10
91,961.70
93,181.40
95,451.70
EBITDA
4,047.00
11,294.10
8,013.90
1,582.00
8,266.10
Other Operating Expense
223.40
-
717.00
-
3,229.10
Non-Operating Interest Income
120.70
133.60
85.50
58.50
98.90
Equity in Affiliates (Pretax)
138.50
2,288.80
115.80
4,195.10
1,307.00
About Unigene Laboratories
View Profile
